| Latest Warner Chilcott News Headlines |
| Date | Time | Source | |
| 11/13/2009 | 7:00AM | PRNUS | Warner Chilcott Announces Secondary Equity Offering
ARDEE, Ireland, Nov. 13 /PRNewswire-FirstCall/ -- Warner Chilcott plc (NASDAQ:WCRX) today announced a 20,000,000 share secondary offering of its ordinary shares by certain selling shareholders. The selling shareholders include funds affiliated with Bain Capital Partners, DLJ Merchant Banking, J.P. Morgan Partners (advised... More...>> |
| 11/09/2009 | 7:00AM | PRNUS | Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2009
Growth of LOESTRIN 24 FE and ESTRACE Cream drive solid earnings growth.
ARDEE, Ireland, Nov. 9 /PRNewswire-FirstCall/ -- Warner Chilcott plc (NASDAQ:WCRX) today announced its results for the quarter ended September 30, 2009. Revenue in the quarter ended September 30, 2009 increased 9.0% to $252.8 million over the prior... More...>> |
| 11/02/2009 | 4:15PM | PRNUS | Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2009 Financial Results
ARDEE, Ireland, Nov. 2 /PRNewswire-FirstCall/ -- Warner Chilcott plc (NASDAQ:WCRX) announced today that it will issue its third quarter 2009 financial results prior to the market opening on Monday, November 9, 2009.
In addition to issuing a press release, the Company will host a conference call for all interested parties... More...>> |
| 10/20/2009 | 4:30PM | PRNUS | Dr. Mahdi B. Fawzi Joins Warner Chilcott as President, Global Research and Development
ARDEE, Ireland, Oct. 20 /PRNewswire-FirstCall/ -- Warner Chilcott plc (NASDAQ:WCRX) announced today that Dr. Mahdi Fawzi has joined the company as President, Global Research and Development. He joins Warner Chilcott from Wyeth Pharmaceuticals, where he was responsible for directing global preclinical development activities.
"Dr... More...>> |
| 09/10/2009 | 4:05PM | PRNUS | Warner Chilcott Files New Lawsuit for Infringement of LOESTRIN(R) 24 FE and FEMCON(R) FE Patents
ARDEE, Ireland, Sept. 10 /PRNewswire-FirstCall/ -- Warner Chilcott plc (NASDAQ:WCRX) announced today that one of its subsidiaries has filed two lawsuits against Lupin Limited and its wholly owned subsidiary Lupin Pharmaceuticals, Inc. (collectively "Lupin") in the District Court for the District of Delaware for infringement... More...>> |
| 08/24/2009 | 8:30AM | PRNUS | Warner Chilcott Acquires P&G's Global Pharmaceuticals Business
P&G Focuses on Winning in Consumer Health Care
CINCINNATI and ARDEE, Ireland, Aug. 24, 2009 /PRNewswire-FirstCall/ -- The Procter & Gamble Company (NYSE:PG) and Warner Chilcott plc (NASDAQ:WCRX) today announced an agreement for the sale of P&G's global pharmaceuticals business to Warner Chilcott for an up-front cash... More...>> |
| 08/03/2009 | 7:00AM | PRNUS | Warner Chilcott Announces Receipt of Paragraph IV Certification Notices
ARDEE, Ireland, Aug. 3 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that it has received two Paragraph IV Certification Notices from Lupin Ltd. ("Lupin"). The Paragraph IV Certification Notices advise the Company of the filing of Abbreviated New Drug Applications (ANDAs) by Lupin... More...>> |
| 05/27/2009 | 2:00PM | PRNUS | Warner Chilcott Announces FDA Acceptance of NDA Submission for Low Dose Oral Contraceptive
ARDEE, Ireland, May 27 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that the U.S. Food and Drug Administration (FDA) has filed for standard review the new drug application (NDA) for WC 3016, a low dose oral contraceptive. The NDA for WC 3016 was submitted by its subsidiary, Warner... More...>> |
| 05/11/2009 | 7:00AM | PRNUS | Warner Chilcott Reports Operating Results for the Quarter Ended March 31, 2009 and Updates 2009 Full Year Guidance
Growth of DORYX, LOESTRIN 24 FE and ESTRACE CREAM drives solid earnings growth.
ARDEE, Ireland, May 11 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) today announced its results for the quarter ended March 31, 2009. Revenue in the quarter ended March 31, 2009 totaled $246.0 million, an increase of 7.2... More...>> |
| 05/11/2009 | 7:00AM | PRNUS | Warner Chilcott Proposes Redomestication From Bermuda to Ireland
ARDEE, Ireland, May 11 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) today announced that its Board of Directors has unanimously approved the redomestication of the Company from Bermuda to Ireland. Subject to the approval of a scheme of arrangement by the Company's stockholders and the approval of... More...>> |
| 05/07/2009 | 12:41PM | PRNUS | Warner Chilcott to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
HAMILTON, BERMUDA, May 7 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that it will present at the Bank of America and Merrill Lynch Healthcare Conference on Tuesday, May 12, 2009 at 10:00 a.m. ET. Presenting for Warner Chilcott will be Roger Boissonneault, President and Chief Executive... More...>> |
| 05/01/2009 | 4:15PM | PRNUS | Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
HAMILTON, Bermuda, May 1 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne") have filed a second lawsuit against Mylan Pharmaceuticals Inc. and Mylan Inc. ("Mylan") in the District Court for the District of New... More...>> |
| 04/27/2009 | 10:31AM | PRNUS | Warner Chilcott Announces Earnings Release Date and Conference Call For First Quarter 2009 Financial Results
HAMILTON, Bermuda, April 27 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that it will issue its first quarter 2009 financial results prior to the market opening on Monday, May 11, 2009.
In addition to issuing a press release, the Company will host a conference call for all interested... More...>> |
| 03/27/2009 | 4:10PM | PRNUS | Warner Chilcott Announces NDA Submission for Low Dose Oral Contraceptive
HAMILTON, Bermuda, March 27 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that its affiliate, Warner Chilcott Company Inc. has submitted a New Drug Application for WC 3016, a low-dose oral contraceptive, to the U.S. Food and Drug Administration.
About Warner Chilcott
Warner Chilcott... More...>> |
| 03/19/2009 | 8:00AM | PRNUS | Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
HAMILTON, Bermuda, March 19 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne") have filed a second lawsuit against Impax Laboratories, Inc. ("Impax") in the District Court for the District of New Jersey for infringement... More...>> |
| 03/17/2009 | 11:51PM | PRNUS | Warner Chilcott Announces Receipt of FDA Response to Citizen Petition
HAMILTON, Bermuda, March 17 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that it has received the FDA's response to its citizen petition requesting that the FDA impose a 30-month stay of approval on Abbreviated New Drug Applications ("ANDAs") referencing DORYX 100 and 75 mg delayed... More...>> |
| 03/17/2009 | 8:30AM | PRNUS | Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
HAMILTON, Bermuda, March 17 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne") have received a Paragraph IV Certification Notice from Impax Laboratories, Inc. ("Impax") advising that Impax has filed an Abbreviated... More...>> |
| 02/27/2009 | 7:00AM | PRNUS | Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008
Growth of promoted product revenue and reduced expenses continue to drive solid cash net income growth
HAMILTON, Bermuda, Feb. 27 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) today announced its results for the quarter and year ended December 31, 2008. Revenue in the quarter ended December 31, 2008... More...>> |
| 02/10/2009 | 4:22PM | PRNUS | Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2008 Financial Results
HAMILTON, Bermuda, Feb. 10 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that it will issue its fourth quarter and full year 2008 financial results prior to the market opening on Friday, February 27, 2009.
In addition to issuing a press release, the Company will host a conference call... More...>> |
| 01/30/2009 | 4:15PM | PRNUS | Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
HAMILTON, Bermuda, Jan. 30 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne") have filed a lawsuit against Actavis Elizabeth LLC ("Actavis") in the District Court for the District of New Jersey for infringement... More...>> |